A tale of terminal differentiation IKKα, the master keratinocyte regulator

Cell Cycle

Volumn 8, Issue 4, 2009, Pages 527-531

  Liu, Bigang ^a   Zhu, Feng ^a   Xia, Ojun ^b   Park, Eumni ^c   Hu, Yinling ^d  

^a UNIVERSITY OF TEXAS   (United States)

^b CENTER FOR CELL AND GENE THERAPY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

EGFR; Ikk ; Keratinocyte differentiation and proliferation; Ras; Tumorigenesis

Indexed keywords

CALCIUM; EPIDERMAL GROWTH FACTOR RECEPTOR; I KAPPA B KINASE ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; RAS PROTEIN;

ANIMAL CELL; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; HOMEOSTASIS; KERATINOCYTE; MITOSIS; MOUSE; NONHUMAN; REGULATORY MECHANISM; REVIEW; SKIN CARCINOGENESIS; SKIN DISEASE; SQUAMOUS CELL CARCINOMA;

EID: 61449184603     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.4.7598     Document Type: Review

References (41)

1. Fuchs E, Byrne C. The epidermis: rising to the surface. Curr Opin Genet Dev 1994; 4:725-36.
2. Ghosh S, Karin M. Missing pieces in the NFkappaB puzzle. Cell 2002; 109:81-96.
3. Hu Y, Baud V, Delhase M, Zhang P, Deerinck T, Ellisman M, et al. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKa subunit of IkB kinase. Science 1999; 284:316-20.
4. Takeda K, Takeuchi O, Tsujimura T, Itami S, Adachi O, Kawai T, et al. Limb and skin abnormalities in mice lacking IKKa. Science 1999; 284:313-6.
5. Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 1999; 284:321-5.
6. Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M, et al. The IKKb subunit of IkB kinase (IKK) is essential for nuclear factor kB activation and prevention of apoptosis. J Exp Med 1999; 189:1839-45.
7. Hu Y, Baud V, Oga T, Kim KI, Yoshida K, Karin M. IKKa controls formation of the epidermis independently of NFkB. Nature 2001; 410:710-4.
8. Sil AK, Maeda S, Sano Y, Roop DR, Karin M. IKKa acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature 2004; 428:660-4.
9. Liu B, Park E, Zhu F, Bustos T, Liu J, Shen J, et al. A critical role for I{kappa}B kinase {alpha} in the development of human and mouse squamous cell carcinomas. Proc Natl Acad Sci USA 2006; 103:17202-7.
10. Maeda G, Chiba T, Kawashiri S, Satoh T, Imai K. Epigenetic inactivation of IkappaB Kinase-alpha in oral carcinomas and tumor progression. Clin Cancer Res 2007; 13:5041-7.
11. Descargues P, Sil AK, Sano Y, Korchynskyi O, Han G, Owens P, et al. IKKalpha is a critical coregulator of a Smad4-independent TGFbeta-Smad2/3 signaling pathway that controls keratinocyte differentiation. Proc Natl Acad Sci USA 2008; 105:2487-92.
12. Van Waes C, Yu M, Nottingham L, Karin M. Inhibitor-kappaB kinase in tumor promotion and suppression during progression of squamous cell carcinoma. Clin Cancer Res 2007; 13:4956-9.
13. Marinari B, Moretti F, Botti E, Giustizieri ML, Descargues P, Giunta A, et al. The tumor suppressor activity of IKKalpha in stratified epithelia is exerted in part via the TGFbeta antiproliferative pathway. Proc Natl Acad Sci USA 2008; 105:17091-6.
14. Park E, Zhu F, Liu B, Xia X, Shen J, Bustos T, et al. Reduction in IkappaB kinase alpha expression promotes the development of skin papillomas and carcinomas. Cancer Res 2007; 67:9158-68.
15. Liu B, Xia X, Zhu F, Park E, Carbajal S, Kiguchi K, et al. IKKalpha is required to maintain skin homeostasis and prevent skin cancer. Cancer Cell 2008; 14:212-25.
16. Sun TT, Green H. Differentiation of the epidermal keratinocyte in cell culture: formation of the cornified envelope. Cell 1976; 9:511-21.
17. Watt FM, Green H. Stratification and terminal differentiation of cultured epidermal cells. Nature 1982; 295:434-6.
18. + gradients in murine epidermis: quantitative measurement using PIXE. J Invest Dermatol 1998; 111:1198-201.
19. Elias PM, Ahn SK, Denda M, Brown BE, Crumrine D, Kimutai LK, et al. Modulations in epidermal calcium regulate the expression of differentiation- specific markers. J Invest Dermatol 2002; 119:1128-36.
20. Yuspa SH, Morgan DL. Mouse skin cells resistant to terminal differentiation associated with initiation of carcinogenesis. Nature 1981; 293:72-4.
21. Bailleul B, Surani MA, White S, Barton SC, Brown K, Blessing M, et al. Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter. Cell 1990; 62:697-708.
22. Wang XJ, Greenhalgh DA, Roop DR. Transgenic coexpression of v-Ha-ras and transforming growth factor alpha increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c-Ha-ras activation. Mol Carcinog 2000; 27:200-9.
23. Dlugosz AA, Hansen L, Cheng C, Alexander N, Denning MF, Threadgill DW, et al. Targeted disruption of the epidermal growth factor receptor impairs growth of squamous papillomas expressing the v-ras(Ha) oncogene but does not block in vitro keratinocyte responses to oncogenic ras. Cancer Res 1997; 57:3180-8.
24. Zhu F, Xia X, Liu B, Shen J, Hu Y, Person M, et al. IKKalpha shields 14-3-3sigma, a G(2)/M cell cycle checkpoint gene, from hypermethylation, preventing its silencing. Mol Cell 2007; 27:214-27.
25. Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B. 14-3-3s is required to prevent mitotic catastrophe after DNA damage. Nature 1999; 401:616-20.
26. Gasco M, Bell AK, Heath V, Sullivan A, Smith P, Hiller L, et al. Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity. Cancer Res 2002; 62:2072-6.
27. Umbricht CB, Evron E, Gabrielson E, Ferguson A, Marks J, Sukumar S. Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene 2001; 20:3348-53.
28. Herron BJ, Liddell RA, Parker A, Grant S, Kinne J, Fisher JK, et al. A mutation in stratifin is responsible for the repeated epilation (Er) phenotype in mice. Nat Genet 2005; 37:1210-2.
29. Li Q, Lu Q, Estepa G, Verma IM. Identification of 14-3-3{sigma} mutation causing cutaneous abnormality in repeated-epilation mutant mouse. Proc Natl Acad Sci USA 2005; 102:15977-82.
30. Fischle W, Wang Y, Allis CD. Binary switches and modification cassettes in histone biology and beyond. Nature 2003; 425:475-9.
31. Zhu F, Park E, Liu B, Xia X, Fischer SM, Hu Y. Critical role of IκB kinase alpha in embryonic development and skin carcinogenesis. Histol Histopathol 2009; 24:265-71.
32. Gandarillas A, Watt FM. c-Myc promotes differentiation of human epidermal stem cells. Genes Dev 1997; 11:2869-82.
33. Dajee M, Tarutani M, Deng H, Cai T, Khavari PA. Epidermal Ras blockade demonstrates spatially localized Ras promotion of proliferation and inhibition of differentiation. Oncogene 2002; 21:1527-38.
34. Yamazaki S, Iwamoto R, Saeki K, Asakura M, Takashima S, Yamazaki A, et al. Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities. J Cell Biol 2003; 163:469-75.
35. Nanney LB, Yates RA, King LE Jr. Modulation of epidermal growth factor receptors in psoriatic lesions during treatment with topical EGF. J Invest Dermatol 1992; 98:296-301.
36. Saleem M, Afaq F, Adhami VM, Mukhtar H. Lupeol modulates NFkappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene 2004; 23:5203-14.
37. Pierceall WE, Goldberg LH, Tainsky MA, Mukhopadhyay T, Ananthaswamy HN. Ras gene mutation and amplification in human nonmelanoma skin cancers. Mol Carcinog 1991; 4:196-202.
38. Leong JL, Loh KS, Putti TC, Goh BC, Tan LK. Epidermal growth factor receptor in undifferentiated carcinoma of the nasopharynx. Laryngoscope 2004; 114:153-7.
39. Balmain A, Pragnell IB. Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene. Nature 1983; 303:72-4.
40. Koster MI, Dai D, Marinari B, Sano Y, Costanzo A, Karin M, Roop DR. p63 induces key target genes required for epidermal morphogenesis. Proc Natl Acad Sci USA 2007; 104:3255-60.
41. Hu YL, Ramsay RG, Kanei-Ishii C, Ishii S, Gonda TJ. Transformation by carboxyl-deleted Myb reflects increased transactivating capacity and disruption of a negative regulatory domain. Oncogene 1991; 6:1549-53.